Plasma kallikrein-mediated activation of the renin-angiotensin system does not require prior acidification of prorenin.

Activation of prorenin in the neutral phase after pH 3.3 dialysis of human plasma depends on clotting factor XII-initiated prekallikrein to kallikrein conversion. Acid dialysis may be necessary for destroying kallikrein inhibitors or rendering prorenin susceptible to attack by kallikrein. If the latter possibility proves true, it is difficult to see how the factor XII-kallikrein pathway could activate prorenin in vivo. Plasma prorenin was therefore separated from active renin and from the protease inhibitors alpha 2-macroglobulin, C1-inactivator, alpha 1-antitrypsin, inter-alpha-trypsin inhibitor, and antithrombin III by gel filtration on Sephadex G-100 and affinity chromatography on Blue Sepharose CL-6B at neutral pH. The resulting prorenin preparation could be activated at pH 7.5 by highly purified human plasma kallikrein, which was prepared from prekallikrein by activation with active factor XII fragment beta-factor XII a. Activation proceeded at 4 and 37 C at a kallikrein concentration of 2 micrograms/ml, which is approximately 5% of the prekallikrein concentration in normal plasma. It appears that an acid-induced conformational change of the prorenin molecule is not required for its activation by plasma kallikrein.

[1]  D. O'Connor,et al.  Renin requires a structural alteration prior to activation by renal kallikrein. , 1980, The Journal of clinical endocrinology and metabolism.

[2]  J. Laragh,et al.  Prorenin and other large molecular weight forms of renin. , 1980, Endocrine reviews.

[3]  J. Griffin,et al.  Immunological studies of prekallikrein, kallikrein, and high-molecular-weight kininogen in normal and deficient plasmas and in normal plasma after cold-dependent activation. , 1980, The Journal of laboratory and clinical medicine.

[4]  J. Griffin,et al.  Human plasma prekallikrein. Studies of its activation by activated factor XII and of its inactivation by diisopropyl phosphofluoridate. , 1980, Biochemistry.

[5]  J. Griffin,et al.  Recent Advances in The Understanding of Contact Activation Reactions , 2008, Seminars in thrombosis and hemostasis.

[6]  J. Laragh,et al.  Initiation of plasma prorenin activation by Hageman factor-dependent conversion of plasma prekallikrein to kallikrein. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[7]  D. Page,et al.  Isolation of completely inactive plasma prorenin and its activation by kallikreins. A possible new link between renin and kallikrein. , 1979, Biochimica et biophysica acta.

[8]  M. Schalekamp,et al.  An intrinsic factor XII–prekallikrein-dependent pathway activates the human plasma renin–angiotensin system , 1979, Nature.

[9]  J. Laragh,et al.  Human urinary kallikrein converts inactive to active renin and is a possible physiological activator of renin , 1978, Nature.

[10]  B. Bennett,et al.  Surface-mediated reactions in the formation of thrombin, plasmin and kallikrein. , 1978, British medical bulletin.

[11]  C. Kluft Determination of prekallikrein in human plasma: optimal conditions for activating prekallikrein. , 1978, The Journal of laboratory and clinical medicine.

[12]  G. Claeson,et al.  Methods for determination of prekallikrein in plasma, glandular kallikrein and urokinase. , 1978, Haemostasis.

[13]  G. Claeson,et al.  Methods for the Determination of Plasmin, Antiplasmin and Plasminogen by Means of the Substrate S-2251 , 1977, Thrombosis and Haemostasis.

[14]  J. Griffin,et al.  [7] Human factor XII (Hageman factor) , 1976 .

[15]  J. Heremans,et al.  Immunochemical quantitation of antigens by single radial immunodiffusion. , 1965, Immunochemistry.